Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

8059 ARTÍCULOS , VIENDO DEL 4111 AL 4125

Drug discovery, development and delivery in Alzheimer's disease

Brambilla D.

Pharm Res. 2017 Dec 29;35(1):3. doi: 10.1007/s11095-017-2329-6.

A review on the hybrids of hydroxycinnamic acid as multi-target-directed ligands against Alzheimer's disease

Zhang X, He X, Chen Q, Lu J, Rapposelli S, Pi R.

Bioorg Med Chem. 2018 Feb 1;26(3):543-550. doi: 10.1016/j.bmc.2017.12.042. Epub 2017 Dec 26.

Similar clinical improvement and maintenance after rTMS at 5 Hz using a simple vs. complex protocol in Alzheimer's disease

Alcalá-Lozano R, Morelos-Santana E, Cortés-Sotres JF, Garza-Villarreal EA, Sosa-Ortiz AL, González-Olvera JJ.

Brain Stimul. 2018 May-Jun;11(3):625-627. doi: 10.1016/j.brs.2017.12.011. Epub 2017 Dec 29.

Alzheimer's Disease: A Systemic Review of Substantial Therapeutic Targets and the Leading Multi-functional Molecules

Umar T, Hoda N.

Curr Top Med Chem. 2017;17(31):3370-3389. doi: 10.2174/1568026618666180112161024.

Dual BACE-1/GSK-3β Inhibitors to Combat Alzheimer's Disease: A Focused Review

Rampa A, Gobbi S, Concetta Di Martino RM, Belluti F, Bisi A.

Curr Top Med Chem. 2017;17(31):3361-3369. doi: 10.2174/1568026618666180112161406.

Multicomponent Reactions for Multitargeted Compounds for Alzheimer`s Disease

Ismaili L, do Carmo Carreiras M.

Curr Top Med Chem. 2017;17(31):3319-3327. doi: 10.2174/1568026618666180112155424.

New Tacrines as Anti-Alzheimer's Disease Agents. The (Benzo)Chromeno- PyranoTacrines

Oset-Gasque MJ, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3349-3360. doi: 10.2174/1568026618666180112155928.

Recent Developments on Multi-Target-Directed Tacrines for Alzheimer's Disease. I. The Pyranotacrines

Romero A, Marco-Contelles J.

Curr Top Med Chem. 2017;17(31):3328-3335. doi: 10.2174/1568026618666180112155639.

Multi-potent Natural Scaffolds Targeting Amyloid Cascade: In Search of Alzheimer's Disease Therapeutics

Chakraborty S.

Curr Top Med Chem. 2017;17(31):3336-3348. doi: 10.2174/1568026618666180116122921.

Objective and Subjective Cognitive Problems among Caregivers and Matched Non-caregivers

Vitaliano PP, Ustundag O, Borson S.

Gerontologist. 2017 Aug 1;57(4):637-647. doi: 10.1093/geront/gnv690.

Differences in diagnostic process, treatment and social Support for Alzheimer's dementia between primary and specialist care: resultss from the Swedish Dementia Registry

Garcia-Ptacek S, Modéer IN, Kåreholt I, Fereshtehnejad SM, Farahmand B, Religa D, Eriksdotter M.

Age Ageing. 2017 Mar 1;46(2):314-319. doi: 10.1093/ageing/afw189.

Effectiveness of a Standardized and Specific Follow-Up in Memory Centers in Patients with Alzheimer's Disease

Rouch L, Cestac P, Cool C, Helmer C, Dartigues JF, Berr C, Rouaud O, Vellas B, Andrieu S; REAL-FR Study Group and the 3C Study Group.

Curr Alzheimer Res. 2017;14(3):255-267. doi: 10.2174/1567205013666161108114850.

A Comparison of Sex Differences in Psychotropic Medication Use in Older People with Alzheimer's Disease in the US and Finland

Moga DC, Taipale H, Tolppanen AM, Tanskanen A, Tiihonen J, Hartikainen S, Wu Q, Jicha GA, Gnjidic D.

Drugs Aging. 2017 Jan;34(1):55-65. doi: 10.1007/s40266-016-0419-5.

[Organizational features influencing health worker's fulfillment in an Alzheimer center and in a nursing home]

Ghiglia S, Garrino L, Gargano A, Raspo S, Pira E, Dimonte V.

G Ital Med Lav Ergon. 2017 Jan;38(4):275-283.

Antipsychotic Use and the Risk of Hip Fracture Among Community-Dwelling Persons With Alzheimer's Disease

Koponen M, Taipale H, Lavikainen P, Tanskanen A, Tiihonen J, Tolppanen AM, Ahonen R, Hartikainen S.

J Clin Psychiatry. 2017 Mar;78(3):e257-e263. doi: 10.4088/JCP.15m10458.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias